1. Home
  2. Companies
  3. Cobalt Ventures
CV

Cobalt Ventures

About

Cobalt’s strategic approach adds value for entrepreneurs and co-investors who seek partners bringing more than just dollars to the mix. While we focus on generating superior financial returns, we’re equally passionate about supporting our portfolio companies with unique industry insights and direct access to healthcare leaders, stakeholders and subject matter experts through our affiliation with a leading regional health plan.

A Flywheel of Value Creation

Cobalt acts as a catalyst for strategic engagement between both the entrepreneurs and corporate partners we serve. Our investment model drives a flywheel of value creation by aligning the strategic priorities of payers and providers with achievement of key commercial milestones for our portfolio companies. Supporting this path for collaboration in both directions is an integral part of our investment process. We start at the earliest stages of evaluating any opportunity -- and continue to work as an active and engaged partner to execute on innovation long after the deal is done.

For Entrepreneurs

Cobalt supports business development and partnership opportunities for:

  • Product development
  • Pilots and use case implementation
  • Business model and ROI validation
  • Customer acquisition
  • Follow-on investment and exits

For Payers and At-Risk Providers

Our portfolio companies drive strategic value by:

  • Lowering total cost of care
  • Improving experience, engagement and quality metrics
  • Expanding access to care for members and patients
  • Aligning payers and providers to value
  • Enhancing business growth and administrative efficiencies

Our Core Principles

Our Team is passionate about forging strong partnerships that drive significant growth and value creation for our portfolio companies. We are committed to the following shared principles and values:

  • We are both financial returns motivated and mission oriented. We believe we can do well by doing good.
  • We are not passive investors. We act with a partnership mentality and seek to work with people who want to actively partner and collaborate with us.
  • We are undeterred by the dysfunction of our healthcare system, and we are obsessed with trying to improve it for payers, providers and patients.
  • We value honesty, integrity and transparency. We expect the same from our partners.
  • We value and support the principles of diversity, equity and inclusion.
  • We do serious and important work in support of incredibly talented entrepreneurs and professionals, but we will always strive to have fun while doing it.

Similar companies

CH

Corewell Health Ventures

From startups to more experienced companies, we offer investment capital joined with the expertise of an integrated health system and health plan. We actively partner with organizations to support their success and positively impact the communities we serve. We also actively partner with other like-minded health care organizations and strategic investors to collectively share expertise and drive scale. By leveraging our venture network, we will drive growth and value for portfolio companies while changing the future of health care. What we invest in:Companies and solutions aligned with our vision and strategic priorities Experienced, in-place management teams Well-developed, unique value propositions and business models Existing customers and revenue stream of $1M or more Solutions that amplify our clinical and operational expertise What we do not invest in:Class III medical devices Pharmaceuticals or biotech Pre-revenue companies* Solutions outside our mission, vision and values Other ways we work with emerging innovation companies to create value:Pool resources De-risk commercialization Collaboration agreements

FC

Flare Capital Partners

At Flare Capital, we do more than simply provide capital for early stage and emerging healthcare technology companies. We partner with the most creative and passionate entrepreneurs aspiring to reinvent the business of healthcare. Together we work to build transformational companies that will profoundly improve the delivery and quality of healthcare while reducing costs. Our Team In 2014, Michael and Bill came together with the vision to build the leading dedicated healthcare technology venture capital firm. Both had started successful venture firms earlier in their careers and had a shared perspective on what the market now needed. As the “business of healthcare” is being transformed, there are significant opportunities to create important and enduring new healthcare technology companies. Given the complexity of this sector, a focused investment strategy with an experienced, committed team is required, and thus Flare Capital was launched. The firm is comprised of a number of proven healthcare technology investors with both deep industry knowledge and venture capital experience alongside accomplished operating executives of leading healthcare organizations. Our Executive Partners have substantial operating experience and our Industry Advisory Board includes many of the brightest healthcare minds with unique perspectives from across the industry. Together they provide critical insights and points of connectivity for our team at Flare Capital and are a tremendous resource for our entrepreneurs. Our Flare Scholars are professionals from preeminent healthcare companies and students from academic institutions across the country who scout interesting people and investment opportunities for us while learning about venture capital. Our Investors We have hand-assembled some of the most successful healthcare organizations, leading family offices, pension funds and investment companies as investors. At Flare Capital, we are privileged to partner with and have unparalleled access to leading innovative healthcare providers, payers, medical device companies, laboratory services provider, healthcare retailer, and one of the largest owners of healthcare campuses. Our investors have an enormous footprint in healthcare and are on the forefront of healthcare innovation. Our Approach We invest across the United States, recognizing that healthcare technology innovation is occurring in many cities around the country. While we consider ourselves principally early stage investors, we are full lifecycle investors. We partner with our entrepreneurs across the entire journey of company building. We are committed to our entrepreneurs and to being their first call, as we work closely and patiently through all strategic issues confronting our companies, maximizing their probability of success. In particular, we are very focused on assisting with recruiting and securing early customer validation and revenues. Starting and then scaling a successful healthcare technology company is hard. Careful and thoughtful financing strategies need to map to detailed product development timelines and other commercial milestones. We closely collaborate with our entrepreneurs to ensure that they have critical access to the best resources as the business scales. We relentlessly strive to be a true partner and to deliver extraordinary value to our entrepreneurs to enable them to build market leading, transformational businesses.

FV

FCA Venture Partners

FCA invests in digital health and technology-enabled healthcare services companies across the seed to late-stage Series A stages. Criteria FCA Venture Partners' flagship fund invests $3-6m as the lead investor in Series A rounds or as a participant in Series B rounds, and our seed fund, FCA Health Innovations, invests $1-3m as a lead investor in seed rounds or as a participant in Series A rounds.

HE

Health Enterprise Partners

Our strategy leverages an extensive hospital system and health plan network of relationships to target attractive market segments, to identify and evaluate investment opportunities, and to support the growth of our portfolio companies. Current Areas of Focus:Administrative Automation Behavioral Health: HCIT & Services Data Security Digital Therapeutics Genomics: Applications & Analytics Patient Safety & Risk Monitoring Pharma Data & Analytics Platforms Social Determinants of Health Virtual Care Models Women’s Health: HCIT & Services

EM

EMCIFund

Address the critical bottlenecks in both established and emerging markets that limit access and affordability to novel cancer solutions. Inculcate the tenets of ESG (Environmental, Social and Governance) based investing and measure the progress and impact of our portfolio using the following metrics: E: The ability to optimize differential drug and device pricing based on geography and expand access to promising products early in their lifecycle S: Ability to boost R&D productivity through operational optimization and process transformation G: Promote ethical conduct of business and collaboration while ensuring inclusion & diversity What We DoInvest in US and EU based cancer start-ups who are keen to explore emerging markets or engage in collaborative R&D. Streamline the product-market fit and ensure access to supportive infrastructure and resources. Facilitate their collaborative R&D/commercialization strategy in geographies of interest. How We Do It Accelerate the path to successful commercialization for US and EU based start-ups developing the next generation of oncology solutions by: Reducing costs through infrastructure consolidation and collaborative expertise Expanded access to capital Facilitating rapid market penetration and commercial scaling​